Page 39 of 293: studies 381 to 390 of 2,926, newest first. Back to the psychedelic-assisted therapy overview
The MIT Press eBooks November 21, 2023 Zoë Dubus 2 citations
International audience
Journal of Psychedelic Studies November 20, 2023 Tahlia R. Harrison 23 citations
Abstract Background and aims Psychedelic-assisted therapy (P-AT) has been shown to reduce post-traumatic stress disorder (PTSD), depression, and anxiety symptoms, and is likely to be approved in the United States (US) in the coming years. However, concerns about participant safety in these early trials have surfaced, including allegations of sexual misconduct. This paper aims to illuminate how...
Deleuze and Guattari Studies October 27, 2023 Patricia Kubala 6 citations
This paper argues that practitioners of psychedelic-assisted therapy could learn a great deal from Deleuze and Guattari’s critique of psychoanalysis in Anti-Oedipus, as well as the practice of materialist psychiatry – schizoanalysis – that they offer in its stead. Much of the clinical research on psychedelics (particularly psilocybin) over the past fifteen years has privileged mystical...
October 4, 2023 Inês Hipólito, Sofia Tzima 2 citations preprint
This paper argues that cultural embodiment plays a pivotal factor in shaping psychological experiences, influencing both the development and treatment of mental health conditions. Traditional analytic philosophy of mind proposes that the efficacy of psychedelic-assisted therapy should be understood as a brain computational model update. Beyond the scientific understanding of neural activity, we...
Journal of Palliative Medicine October 1, 2023 Noah D Gold, Austin J. Mallard, Jacob C Hermann et al. 5 citations
Background: Amyotrophic lateral sclerosis (ALS) is an aggressive, terminal neurodegenerative disease that causes death of motor neurons and has an average survival time of 3-4 years. ALS is the most common motor neuron degenerative disease and is increasing in prevalence. There is a pressing need for more effective ALS treatments as available pharmacotherapies do not reverse disease progression...
Current Psychiatry Reports October 1, 2023 Aaron Wolfgang, Charles W Hoge 15 citations
This review discusses the current and projected landscape of psychedelic-assisted therapy (PAT), with a focus on clinical, legal, and implementation considerations in Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. 3,4-Methylenedioxymethamphetamine (MDMA)- and psilocybin-assisted therapy have shown promising outcomes in efficacy, safety, tolerability, and...
Frontiers in Psychiatry September 28, 2023 Lauren Johansen, Paul Liknaitzky, Maja Nedeljkovic et al. 5 citations
As investigations into the efficacy of psychedelic-assisted psychotherapy to treat depression continue, there is a need to study the possible mechanisms of action that may contribute to the treatment's antidepressant effects. Through a two-round Delphi design, the current study investigated experts' opinions on the psychological mechanisms of action associated with the antidepressant effects of...
Philosophical Psychology September 25, 2023 Héloïse Athéa 1 citation
Dating back to the late 1990s, the growing popularity of psychedelics is not a recent trend. Psychiatrists, psychologists, and neuroscientists are paying increasing attention to these hallucinogeni...
Frontiers in Psychiatry September 20, 2023 Taylor Black 2 citations
Psychedelic-assisted treatment (PAT) for mental health is in renaissance. Psilocybin and MDMA stand near FDA approval, and US cities and states are decriminalizing or regulating the non-clinical use of psilocybin. However, neither FDA indications nor a regulated use model sufficiently address the complex needs and opportunities for an improved treatment of addiction. When paired with disability...
Journal of Psychoactive Drugs September 18, 2023 Emmy Manson, Erin Ryding, Wes Taylor et al. 13 citations
Novel and traditional psychedelic medicines are attracting interest as potential treatments of mental illness. Before psychedelic therapies can be made available in culturally safe and effective ways to diverse peoples, the field must grapple with the complex legacies of colonialism and ongoing clashes between biomedical and Indigenous Ways of Knowing. This article presents results of a pilot...